Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$481,273
+$18,549 QoQ
Shares Held
1,895
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#3,741
of 4,676 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sage Capital Management, LLC holds $2,235,834 across 3 Drug Manufacturers - General names. JNJ ranks #3 (21.5% of the industry book) .
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481,273 | 1,895 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $462,724 | 1,893 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $391,756 | 1,893 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $513,798 | 2,771 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $421,742 | 2,761 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $456,060 | 2,750 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $396,258 | 2,740 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $454,092 | 2,802 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $407,932 | 2,791 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $439,768 | 2,780 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $434,013 | 2,769 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||